STAAR Surgical Names Deborah Andrews Interim CFO Steve Brown Resignation Effective

STAAR Surgical Names Deborah Andrews

Steve Brown Resignation Effective April

MONROVIA, CA, April 5, 2017---STAAR

Surgical Company (NASDAQ: STAA) a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems

for the eye, announced today that Steve Brown has resigned his position as Chief Financial Officer effective April 28, 2017. Deborah

Andrews, currently Chief Accounting Officer, will step in as Interim CFO. Deborah was formerly CFO of STAAR from 2005 to 2013.

"My decision to leave STAAR Surgical

was difficult to say the least. I would characterize the decision as one of lifestyle and commitment to family. I have determined

that pursuing an opportunity within a manageable commuting distance was an essential element in achieving this outcome. I am fortunate

to be in the position to make this positive change, all the while, regretting that I am leaving STAAR as the company is achieving

its intended transformative three year plan goals. I am confident that the company will thrive in the future with the solid management

team and extraordinary technology it possesses," said Steve Brown.

"We thank Steve for his many contributions to STAAR and

wish him the very best as he pursues new opportunities. He has been a great partner and tireless advocate for the company. He has

worked closely with Deborah in her role as CAO and through their collaborative work, we are in an excellent position to achieve

a seamless transition," said Caren Mason, President and CEO. "We will initiate a search for a permanent replacement

in the near term. We believe we have an outstanding opportunity for an accomplished CFO with outstanding public company credentials.

STAAR continues to execute on its strategic priorities and we are pleased to be delivering visual freedom to a growing number of

patients globally," added Mason.

About STAAR Surgical

STAAR, which has been dedicated solely

to ophthalmic surgery for over 25 years, designs, develops, manufactures and markets implantable lenses for the eye with companion

delivery systems. These lenses are intended to provide visual freedom for patients lessening or eliminating the reliance on glasses

or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's

lens used in refractive surgery is called an Implantable Collamer Lens or "ICL". To learn more about the ICL go

to: www.discovervisianicl.com. STAAR has approximately 300 employees and markets lenses in over 60 countries. Headquartered in

Monrovia, CA, the company operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA. For more information, please visit

the Company's website at www.staar.com.

All statements in this press release that are not statements

of historical fact are forward-looking statements, including statements about any of the following: future prospects of the Company

or its technology and any assumptions underlying any of the foregoing. Important factors that could cause actual results to differ

materially from those indicated by such forward-looking statements are set forth in the Company's Annual Report on Form 10-K

for the year ended December 31, 2016, under the caption "Risk Factors", which is on file with the Securities and Exchange

Commission and available in the "Investor Information" section of the company's website under the heading "SEC

These statements are based on expectations and assumptions as

of the date of this press release and are subject to numerous risks and uncertainties, which could cause actual results to differ

materially from those described in the forward-looking statements.